| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |